Study guide

12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

Certified Nuclear Medicine Technologist CNMT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current CNMT Exam Facts 1.2 How to Use This Guide

2 Radiation Physics Fundamentals

2.1 Radioactive Materials, Isotopes, and Decay Modes 2.2 Decay Calculations and Counting Statistics 2.3 Interactions of Radiation with Matter 2.4 Radiation Detector Types and Principles

3 Biological Effects & ALARA

3.1 Biological Effects of Radiation Exposure 3.2 ALARA and Protection Calculations 3.3 Dose Limits, Surveys, and Personal Monitoring

4 NRC & Regulatory Compliance

4.1 NRC Areas, Spills, Waste, and Records 4.2 Written Directives and DOT Shipping 4.3 EPA, OSHA, HIPAA, FDA, and USP Standards 4.4 Radioactive Waste Disposal and Regulatory Records

5 Generators & Kit Preparation

5.1 Radionuclide Generators and Quality Control 5.2 Radiopharmaceutical Kit Preparation 5.3 Radiopharmaceutical Quality Control

6 Tc-99m Diagnostic Agents

6.1 Tc-99m Cardiac Imaging Agents 6.2 Tc-99m Bone, Renal, and GU Agents 6.3 Tc-99m GI and Hepatobiliary Agents 6.4 Tc-99m CNS, Infection, and Labeled Cells

7 Non-Tc Diagnostic & PET Agents

7.1 Iodine and Indium Diagnostic Agents 7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents 7.3 PET Radiopharmaceuticals 7.4 Neurologic, Breast, and Neuroendocrine PET Agents

8 Therapeutics, Adjuncts & Administration

8.1 Therapeutic Radiopharmaceuticals 8.2 Interventional and Adjunct Pharmaceuticals 8.3 Blood Labeling and Administration Techniques 8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents

9 Non-Imaging Instrumentation

9.1 Well Counters, Probes, and Survey Meters 9.2 Dose Calibrator Quality Control 9.3 Auxiliary and Patient Care Equipment

10 Imaging Systems & Quality Control

10.1 Gamma Camera Quality Control 10.2 SPECT and SPECT/CT Systems 10.3 PET and PET/CT Systems and QC 10.4 CT Systems, PACS, and Information Systems 10.5 CT Radiation Dose, Safety Alerts, and Protocol Optimization

11 Pulmonary, Bone, Oncology & Infection Imaging

11.1 Pulmonary Imaging Procedures 11.2 Bone and Musculoskeletal Imaging 11.3 Oncology Imaging Procedures 11.4 Infection Imaging Procedures

12 Renal, Endocrine & Hematopoietic Imaging

12.1 Renal and Genitourinary Imaging 12.2 Endocrine Imaging (Thyroid, Parathyroid, Adrenal) 12.3 Hematopoietic and Bone Marrow Imaging 12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

13 Cardiovascular Procedures

13.1 Myocardial Perfusion Imaging 13.2 Cardiac Function, Viability, and Special Studies 13.3 Exercise and Pharmacologic Stress Testing

14 GI, CNS, Therapy & Hybrid CT Procedures

14.1 Gastrointestinal Procedures 14.2 Central Nervous System Procedures 14.3 Radionuclide Therapy Procedures 14.4 CT and Hybrid Imaging in Nuclear Medicine 14.5 CSF Studies: Cisternography, Leak Localization, and Shunt Patency

15 Patient Care & Clinical Workflow

15.1 Patient Care, Education, and Consent 15.2 Scheduling and Radiopharmaceutical Procurement 15.3 Acquisition, Positioning, and Image Quality 15.4 Image Processing and Quantitative Analysis 15.5 Non-Imaging Studies: Specimens, Counting, and Error Analysis

12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

Key Takeaways Explain This Topic AI

Percent radioactive iodine uptake equals (neck counts minus thigh background) divided by (decay-corrected standard counts minus room background), multiplied by 100—every term must be collected with matched geometry and count time.

The standard is a capsule identical to the administered dose counted in a neck phantom at the same probe distance, and it must be decay-corrected to the time of the patient count before the ratio is formed.

Typical adult 24-hour uptake reference ranges run roughly 10–30 percent, but each laboratory establishes its own values; high uptake with thyrotoxicosis suggests Graves disease or a toxic nodule, while low uptake suggests thyroiditis or exogenous hormone.

Recent iodinated contrast, amiodarone, kelp or iodine supplements, and thyroid medications suppress measured uptake—amiodarone can interfere for many months, so always document the exposure date.

Whole-body radioiodine surveys use I-123 or low-activity diagnostic I-131 after TSH stimulation by hormone withdrawal or recombinant human TSH plus a low-iodine diet; larger diagnostic I-131 activities risk stunning subsequent therapy uptake.

Last updated: August 2026

12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

Quick Answer: %RAIU = [(neck − thigh) ÷ (decay-corrected standard − room background)] × 100. Count the standard in a neck phantom at the same distance as the patient, use the same count time , and decay-correct the standard to the counting moment. Typical adult 24-hour uptake is roughly 10–30% (laboratory-specific). Iodine load suppresses uptake —contrast for weeks, amiodarone for months.

Section 12.2 covered thyroid imaging clinically and Section 9.1 covered the uptake probe as hardware. This section is the measurement itself: geometry, counts, arithmetic, and the interferences that make the number meaningless.

The Instrument and Its Geometry

A thyroid uptake system is a 2-inch × 2-inch NaI(Tl) scintillation detector with a flat-field (open-bore) collimator , a photomultiplier tube, and a pulse-height analyzer set on the appropriate photopeak ( 159 keV for I-123, 364 keV for I-131).

Geometry rule Why it matters

Fixed probe-to-neck distance (commonly about 25–30 cm , per the system) Counts fall off with the inverse square of distance; a 10% distance error is a large count error

Same distance for the standard in a neck phantom The ratio only cancels geometry if both terms share it

Consistent patient positioning — supine or seated, neck extended, chin up Reproducibility across the 4–6 hour and 24 hour points

Same count time for every measurement Counts, not count rates, go into the ratio unless you normalize

Before any patient measurement, verify the daily constancy and energy peaking of the counting system, and run a chi-square test on the schedule the department sets (Section 9.1).

The Four Counts

Count What it is

Standard A capsule from the same lot and activity as the patient dose, counted in a neck phantom at the standard distance, before the dose is given

  • Room background The counting room with the standard and patient removed—subtracted from the standard
  • Neck (patient) Over the thyroid at the fixed distance at each protocol time point

Thigh (patient background) Over the mid-thigh at the same distance and time, representing circulating and soft-tissue activity — subtracted from the neck count

  • The Calculation
  • %RAIU = [(neck counts − thigh counts) ÷ (standard counts − room background)] × 100

with the standard decay-corrected from its counting time to the time of the patient count.

Worked example — 24-hour I-123 uptake.

  • Standard counted at administration: 420,000 counts/min; room background 300 counts/min → net standard 419,700
  • I-123 half-life 13.2 h ; elapsed 24 h → decay factor = (½)^(24/13.2) = (½)^1.818 ≈ 0.284
  • Decay-corrected net standard at 24 h ≈ 419,700 × 0.284 ≈ 119,200 counts/min
  • Patient neck at 24 h: 28,000 counts/min; thigh: 1,400 counts/min → net neck 26,600
  • %RAIU ≈ 26,600 ÷ 119,200 × 100 ≈ 22%

That result sits inside a typical adult 24-hour reference band. Note what happens if you forget to decay-correct : 26,600 ÷ 419,700 ≈ 6.3% , a falsely "low uptake" result that could be misread as thyroiditis. Decay correction is the single most common arithmetic failure on this study.

Reference Ranges and Interpretation

  • Pattern Teaching interpretation
  • High uptake + thyrotoxic labs Graves disease, toxic multinodular goiter, toxic adenoma

Low uptake + thyrotoxic labs Thyroiditis (subacute, silent, postpartum), exogenous thyroid hormone, recent iodine load

Low uptake + hypothyroid labs Advanced Hashimoto disease, prior ablation or surgery

Elevated early (4–6 h) uptake with rapid fall by 24 h Rapid-turnover Graves pattern; some labs add early time points for therapy dose calculation

Reference ranges differ by laboratory and by dietary iodine intake in the served population — use your own laboratory's values , commonly around 5–15% at 4–6 hours and 10–30% at 24 hours.

Interferences That Invalidate the Measurement

  • Exposure Approximate interference window
  • Iodinated IV or oral CT contrast Weeks to months
  • Amiodarone Many months (large iodine reservoir in fat)
  • Kelp, iodine supplements, povidone-iodine antiseptic Days to weeks
  • Levothyroxine / liothyronine Suppresses TSH drive; held only on physician order
  • Antithyroid drugs (methimazole, PTU) Alter organification and uptake
  • Recent radiopharmaceutical administration Residual activity contaminates counts

Document the date of any exposure — an item stem that mentions a CT with contrast last week and a "surprisingly low uptake" is testing exactly this.

Whole-Body Radioiodine Surveys

After thyroidectomy for differentiated thyroid cancer, whole-body imaging maps iodine-avid remnant and metastases.

Element Standard practice

TSH stimulation Thyroid hormone withdrawal (endogenous TSH rise) or recombinant human TSH (Thyrogen®) injections

Diet Low-iodine diet , commonly about 1–2 weeks before dosing

Tracer I-123 whole-body, or diagnostic I-131 at low activity (commonly a few millicuries, protocol and regulation dependent)

Imaging times I-123 often about 24 hours ; diagnostic I-131 may add 48–72 hour views

Acquisition Whole-body sweep plus spot views; high-energy collimator for I-131 , low-energy high-resolution for I-123

Post-therapy scan Performed days after a therapy administration and is more sensitive than the diagnostic scan because of the far higher activity

Stunning is the high-yield concept: a larger diagnostic I-131 activity can transiently reduce the uptake of the subsequent therapeutic dose. Many centers avoid it by using I-123 or minimal diagnostic I-131 activity.

Physiologic activity on a survey — salivary glands, stomach, bowel, bladder, nasopharynx, and sometimes lactating breast — must not be called metastatic. Contamination from saliva, urine, or sweat is the other classic false positive; have the patient void, wash, and change into a gown before repeat views.

Bottom line: matched geometry, four counts, decay-corrected standard, documented iodine history. Get those right and the number means something.